维普中文期刊产品整合服务
24篇 您的检索式:作者名="Frost AE"
    题名 作者 年代 出处 被引量
1Sibutramine in the treatment of overweight non-insulin dependent diabetics 显示文摘 Brynes AE Frost G Int J Obes0,19,2:1
2Patient, clinician, and population porspectives on determining the clinical significance of Quality - of - life scores 显示文摘Frost MH Bonomi AE Ferrans CE eta/ 2002MayoClinProe2002,77,5:1
3Patient, clinician, and population perspectives on determining the clinical significance of quality - of - life scores显示文摘Frost MH Bonomi AE Ferrans CE 2002Mayo Clinic Proceedings2002,77,5:1
4Patient,clinician and population perspectives on determining the clinical significance of quality-of-life scores显示文摘Frost MH Bonomi AE Ferrans CE 2002Mayo Clinic Proceedings2002,77,55:1
5Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader- Willi syndrome显示文摘Goldstone AP Brynes AE Thomas EL Bell JD Frost G Holland A 2002Am J Clin Nutr2002,75,3:1
6Bronehiolitis obliterans:the Achilles heel of lung transplantation显示文摘Frost AE 2002Verb K Acad Geneeskd Belg2002,64,5:1
7Ghrelin enhances appetite and increases food intake in humans显示文摘Wren AM Seal LJ Cohen MA Brynes AE Frost GS Murphy KG 2001J Clin Endocrinol Metab2001,86,12:1
8Initial use of am- brisentan plus tadalafil in pulmonary arterial hyperten- sion显示文摘Gali N Barberh JA Frost AE 2015N Engl J Med2015,373,9:1
9ARIES-1 : a placebocontrolled efficacy and safety study of ambrisentan in patients with pulmonary arterial hypertension显示文摘OUDIZ R J TORRES F FROST AE et ol 2006CHEST2006,130,:1
10Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities显示文摘MCGOON MD FROST AE OUDIZ R J 2009Chest2009,135,1:1
11Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution显示文摘Goldstone AP Thomas EL Brynes AE Bell JD Frost G Saeed N 2001J Clin Endocrinol Metab2001,86,9:1
12Ambrisentan therapy in patients with pulmonary arterial hypertension who discontin- ued bosentan or sitaxsentan due to liver function test abnormali- ties 显示文摘McGoon MD Frost AE Oudiz RJ 2009Chest2009,135,1:1
13ARIES-1 : A placebo-controlled, efficacy and safety study of ambrisentan in patients with pulmonary arterial hypertension 显示文摘OUDIZ RJ TORRES F FROST AE 2006Chest2006,130,4:1
14Diet-induced change in fatty acid composition of plasma triacylglycerols is not associated with change in glucagon-like peptide 1or insulin sensitivity in people with type 2 diabetes显示文摘Brynes AE Edwards CM Jadhav A Ghatei M Bloom SR Frost GS 2000Am J Clin Nutr2000,72,5:1
15International guidelines for the selection of lung transplant candidates 显示文摘Maurer JR Frost AE Glanville AR 1998Transplantation1998,66,7:1
16Demographics and Outcomes of Patients Diagnosed with Pulmonary Hyperten- sion with Pulmonary Capillary Wedge Pressures 16 to 18 mmHg: Insights From the Reveal Registry 显示文摘Frost AE Farber HW Barsc R J 2013Chest2013,143,1:1
17Transition from epoprostenol and treprostinil to the oral endothelin receptor antagonist bosentan in patients with pulmonary hypertension 显示文摘Suleman N Frost AE 2004Chest2004,126,3:1
18Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol 显示文摘Frost AE Quinones MA Zoghbi WA 2005J Heart Lung Transplant2005,24,4:1
19Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease 显示文摘Girgis RE Frost AE Hill NS 2007Ann Rheum Dis2007,66,:1
20Ambrisentan therapy in patients with pulmonary arterial hypertension who discontin- ued bosentan or sitaxsentan due to liver function test abnor- malities显示文摘McGoon MD Frost AE Oudiz R J 2009Chest2009,135,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费